Surveying the Safety of NOACs in the Real World

Program Goals

Introduction: Management of VTE

NOACs in VTE Setting: Transformation in Clinical Practice

Clinical Trials Data vs Real-World/ Registry Data

Real-World NOACs Database

Adherence to VKAs

Persistence With NOACs: Community Pharmacies Data

Persistence With Rivaroxaban The Dresden Non-interventional Anticoagulation Registry

NOACs Risk of Major Bleeding in VTE: Clinical Trials

XANTUS Rivaroxaban Registry

NOAC Trials: NOACs vs Warfarin Efficacy and Safety

NOACs Treatment Selection in VTE

NOACs Dose Reduction

Summary

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)